CHARLENE FARTHING: Open Payments
NPI 1679627434 · NORTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 27 payments from 11 companies in 2025. Trend: 2023 $541 · 2024 $653 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $92 |
| ABBVIE INC. | 4 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| Janssen Biotech, Inc. | 3 | $57 |
| UCB, Inc. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Incyte Corporation | 1 | $26 |
| Biofrontera Inc. | 1 | $24 |
| Amgen Inc. | 1 | $21 |
Products named: ILUMYA, COSENTYX, TREMFYA, Bimzelx, RINVOQ, DUPIXENT, SKYRIZI, LIBTAYO.
Industry payments across VA — which companies pay providers there.
